Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2023 Earnings Call Transcript

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2023 Earnings Call Transcript November 8, 2023 Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.02, expectations were $0.68. Operator: Thank you for standing by. My name is Danika and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Ligand Third Quarter […]

Related Keywords

Japan ,New York ,United States ,China ,Xintong ,Guizhou ,Beijing ,Chinese ,Primrose Bio ,Amgen Kyprolis ,Novan Sitavig ,Matthew Korenberg ,Tavo Espinoza ,Todd Davis ,Matt Hewitt ,Amgen ,Novartis ,European Bank Stocks To Invest ,Primordial Genetics ,Viking Therapeutics ,Both Verona ,With Filspari ,Investor Day ,Micro Cap Stocks To Invest ,